Using a yeast two-hybrid screen, the neuronal membrane glycoprotein M6a, a member of the proteolipid protein family, was identified to be associated with the -opioid receptor (MOPr). Bioluminescence resonance energy transfer and co-immunoprecipitation experiments confirmed that M6a interacts agonist-independently with MOPr in human embryonic kidney 293 cells co-expressing MOPr and M6a. Co-expression of MOPr with M6a, but not with M6b or DM20, exists in many brain regions, further supporting a specific interaction between MOPr and M6a. After opioid treatment M6a co-internalizes and then co-recycles with MOPr to cell surface in transfected human embryonic kidney 293 cells. Moreover, the interaction of M6a and MOPr augments constitutive and agonist-dependent internalization as well as the recycling rate of -opioid receptors. On the other hand, overexpression of a M6a-negative mutant prevents -opioid receptor endocytosis, demonstrating an essential role of M6a in receptor internalization. In addition, we demonstrated the interaction of M6a with a number of other G protein-coupled receptors (GPCRs) such as the ␦-opioid receptor, cannabinoid receptor CB1, and somatostatin receptor sst2A, suggesting that M6a might play a general role in the regulation of certain GPCRs. Taken together, these data provide evidence that M6a may act as a scaffolding molecule in the regulation of GPCR endocytosis and intracellular trafficking.The clinical utility of opiates is greatly limited by adaptive changes in the nervous system causing tolerance, dependence, and addiction. These adaptive changes are initiated by binding of opiate drugs to opioid receptors that are also activated by endogenous opioid peptides (1). The -opioid receptor mediates the analgesic effects of opioids but is also important for initiating adaptive changes in the nervous system causing opioid tolerance, dependence, and addiction (2-4). On the cellular level, the repeated opioid exposure induces a rapid phosphorylation of intracellular receptor domains, leading to receptor desensitization followed by receptor internalization (5). Internalized receptors can be sorted either to a degradative pathway for down-regulation or recycling pathway for reactivation (6). There is increasing evidence that the trafficking and signaling of opioid receptors are regulated by direct interaction with membranal and/or cytosolic proteins (7).In the course of identifying new -opioid receptor-interacting proteins using a yeast two-hybrid method, we isolated a cDNA encoding for the membrane glycoprotein M6a. M6a is a member of the proteolipid protein (PLP) 2 family of tetraspan membrane proteins and mainly expressed in neurons (8 -10). M6a shares 40% homology with DM20, the smaller splice isoform of the major central nervous system myelin proteolipid PLP, which is mainly expressed in myelinating glial cells (11). M6a is 55% homologous to proteolipid M6b, which is expressed in neurons and oligodendrocytes (8,9,12). M6a is suggested to play a role as a modulator for neurite outgrowth (13) ...